1. Fukatsu, Asuki, Ishiguro, Futoshi, Tanaka, Ichidai, Hata, Yutaka, Sekido, Yoshitaka. 2013. RASSF3 downregulation increases malignant phenotypes of non-small cell lung cancer. In Lung cancer (Amsterdam, Netherlands), 83, 23-9. doi:10.1016/j.lungcan.2013.10.014. https://pubmed.ncbi.nlm.nih.gov/24246507/
2. Kudo, Takumi, Ikeda, Mitsunobu, Nishikawa, Misa, Nakagawa, Kentaro, Hata, Yutaka. 2012. The RASSF3 candidate tumor suppressor induces apoptosis and G1-S cell-cycle arrest via p53. In Cancer research, 72, 2901-11. doi:10.1158/0008-5472.CAN-12-0572. https://pubmed.ncbi.nlm.nih.gov/22593196/
3. Beveridge, Dianne J, Richardson, Kirsty L, Epis, Michael R, Woo, Andrew J, Leedman, Peter J. 2021. The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer. In Scientific reports, 11, 18003. doi:10.1038/s41598-021-97190-x. https://pubmed.ncbi.nlm.nih.gov/34504167/
4. Tommasi, Stella, Dammann, Reinhard, Jin, Seung-Gi, Avruch, Joseph, Pfeifer, Gerd P. . RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. In Oncogene, 21, 2713-20. doi:. https://pubmed.ncbi.nlm.nih.gov/11965544/
5. Jacquemart, Isabelle C, Springs, Alison E B, Chen, Wen Y. . Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice. In International journal of oncology, 34, 517-28. doi:. https://pubmed.ncbi.nlm.nih.gov/19148488/
智鼠故事 
